AZD 2066 inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets mGluR5.
Molecular Weight
381.82
Molecular Formula
C19H16ClN5O2
Targets
mGluR5
Form
Lyophilized powder
Purity
>98%
Applications
AZD 2066 can be studied for its effect on increasing muscle mass and strength, improving bone mineral density, and potentially enhancing physical performance.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
